You are here
PFIZER ONCOLOGY PRESS KIT PAGE
PLEASE NOTE: All assets on this page are intended for use by media professionals.
Pfizer Oncology is committed to the discovery, investigation and development of innovative treatment options to improve the outlook for patients across a wide range of cancers. For the latest information on our growing pipeline, product portfolio and collaborations with the broader cancer community, visit this page periodically for leadership perspective, fact sheets, videos and other media resources.
We also encourage you to visit our other online resources for additional information on Pfizer Oncology.
Click here to learn more about how Pfizer Oncology is helping to redefine life with cancer.
Click here to learn more about Pfizer’s unique combination approach and pipeline.
PFIZER AT ESMO 2017
At the European Society for Medical Oncology (ESMO) Congress being held from September 8-12, 2017 in Madrid, Pfizer will share new data on 13 of our marketed therapies and investigational compounds across multiple solid tumors and hematologic cancers. Learn more about Pfizer at ESMO:
Hear from Pfizer Leadership
Group President, Pfizer Innovative Health
Global President and General Manager, Pfizer Oncology
President, North America Oncology at Pfizer
Chief Medical Officer, Pfizer Oncology
Chief Development Officer, Oncology, Pfizer Global Product Development